Loss of TROP2 function in humans results in gelatinous drop-like corneal dystrophy (GDLD), characterized by accumulation of gelatinous amyloid masses within or beneath corneal epithelium, leading to blindness (Tsujikawa et al., 1999). Here, TACSTD2 is linked to gelatinous drop-like corneal dystrophy.